Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
2.203
+0.003 (0.15%)
May 16, 2025, 9:34 AM - Market open

Oramed Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2021 2016 - 2020
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Aug '21 2016 - 2020
Market Capitalization
919893471544640
Upgrade
Market Cap Growth
4.69%4.69%-80.20%-13.48%-15.00%479.35%
Upgrade
Enterprise Value
-52-46-9311444565
Upgrade
Last Close Price
2.202.422.3112.0314.2819.68
Upgrade
PE Ratio
--16.87---
Upgrade
PS Ratio
--69.54174.08200.54236.73
Upgrade
PB Ratio
0.600.670.573.113.265.49
Upgrade
P/TBV Ratio
0.610.670.573.103.275.53
Upgrade
EV/Sales Ratio
---115.15163.83208.87
Upgrade
Debt / Equity Ratio
0.000.000.320.010.000.01
Upgrade
Asset Turnover
--0.010.02-0.03
Upgrade
Quick Ratio
24.9724.973.0527.1019.8514.10
Upgrade
Current Ratio
25.1925.193.0627.3420.0814.27
Upgrade
Return on Equity (ROE)
-12.39%-12.39%3.24%-23.77%--30.78%
Upgrade
Return on Assets (ROA)
-4.25%-4.25%-5.16%-14.95%--17.54%
Upgrade
Return on Capital (ROIC)
-4.44%-4.44%-5.38%-15.90%--20.18%
Upgrade
Earnings Yield
-21.21%-19.54%5.93%-7.77%-6.44%-3.48%
Upgrade
FCF Yield
-9.38%-8.64%-11.32%-6.04%-6.14%-3.37%
Upgrade
Buyback Yield / Dilution
-0.65%-0.65%-4.02%-5.08%-30.36%-16.71%
Upgrade
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q